Menu
Recruiting NCT07418450

Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?

No phase Interventional Lung Cancer (Diagnosis)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: EBUS-TBNA.
Who it may be relevant to
Registry conditions: Lung Cancer (Diagnosis). Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Austria
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Discrimination of N2a and N2b by EBUS-TBNA: is a Needle Change Necessary? - a Prospective Pilot Study

Overview

During EBUS staging in patients with mediastinal lymphadenopathy, it is planned to perform a first round of staging with change of the needle between all lymph nodes and a second round of staging without change of the needle.

Interventions

  • Diagnostic test EBUS-TBNA
    During EBUS staging, the needle well be changed between all lymph node stations in a first round. The EBUS staging will be repeated without the change of the needle between the lymph node stations.

Primary outcome measures

  • Agreement between the two rounds of EBUS staging [Time frame: 18 months]

Eligibility criteria

Inclusion criteria

  • Pulmonary lesion suspicious for lung cancer or histologically confirmed lung cancer
  • indication for mediastinal staging

Exclusion criteria

\-

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Non-randomized
Model
Single group
Masking
Open label
Primary purpose
Diagnostic

Study locations

Austria · 1 center
  • Medical University of Vienna — Vienna

Identifiers

NCT: NCT07418450 · 1.1 Needle change

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗